Omnicell (OMCL) EBITDA Margin (2010 - 2026)
Omnicell's EBITDA Margin came in at 16.57% for Q2 2026, up 6.78 percentage points from 9.79% a year earlier and up 4.97 percentage points from the prior quarter.
Powered by 
Analysis
Omnicell (OMCL) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Omnicell reported EBITDA Margin of 10.97%, up 2.40 percentage points year-over-year; for FY2025, it was 7.31%, down 0.45 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -4.05 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 7.76% in FY2024 (+2.81 pp), 4.96% in FY2023 (-1.89 pp), 6.85% in FY2022 (-9.15 pp) and 16.00% in FY2021 (+4.64 pp).
- The Q2 2026 figure represents the highest quarterly EBITDA Margin since Q3 2021.
- Year-over-year, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +3.25 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2024 (a gain of 10.97 percentage points), and the weakest in Q4 2022 (a drop of 16.74 percentage points).
- Business Quant data shows OMCL's EBITDA Margin at 11.60% (Q1 2026), 6.60% (Q4 2025) and 9.12% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 257.79 Bn | 234.30 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 190.83 Bn | 164.70 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 162.10 Bn | 141.75 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 158.05 Bn | 138.34 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 130.31 Bn | 95.56 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 124.76 Bn | 110.95 Bn | 4.25 Bn | 20.38% |
| 7 | Boston Scientific | 62.03 Bn | 57.46 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 58.73 Bn | 41.94 Bn | 1.35 Bn | 20.05% |
| 9 | Becton Dickinson | 58.33 Bn | 55.48 Bn | 2.32 Bn | 24.62% |
| 10 | Omnicell | 1.71 Bn | 671.26 Mn | 137.83 Mn | 10.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 10.99% |
| Jun 30, 2026 | 16.57% |
| Mar 31, 2026 | 11.60% |
| Dec 31, 2025 | 6.60% |
| Sep 30, 2025 | 9.12% |
| Jun 30, 2025 | 9.79% |
| Mar 31, 2025 | 3.38% |
| Dec 31, 2024 | 10.82% |
| Sep 30, 2024 | 9.82% |
| Jun 30, 2024 | 9.03% |
| Mar 31, 2024 | 0.17% |
| Dec 31, 2023 | -0.15% |
| Sep 30, 2023 | 8.81% |
| Jun 30, 2023 | 10.33% |
| Mar 31, 2023 | 0.02% |
| Dec 31, 2022 | -5.11% |
| Sep 30, 2022 | 11.88% |
| Jun 30, 2022 | 10.69% |
| Mar 31, 2022 | 8.55% |
| Dec 31, 2021 | 11.63% |
API Access
Omnicell EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OMCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "OMCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OMCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();